MAP2K7 and cancer: Chan et al. showed that the downregulation of protein methyltransferase 6 (PRMT6) suppresses MEK/ERK signaling in hepatocellular carcinoma (HCC) and promotes cancer stemness and tumor-initiating properties of HCC cells34.